How to Spot Counterfeit Ozempic

Counterfeit Ozempic is not a theoretical problem. The FDA has seized fake pens inside the legitimate U.S. drug supply chain at least three separate times, most recently in December 2025 [1]. That means a pen that came from a real pharmacy is not automatically safe, which is an uncomfortable thing to say and the reason this checklist exists.

This guide covers the physical checks, the lot numbers FDA has named, and what to do if you suspect you have a fake. It is not medical advice. If you think you used a counterfeit product, contact a healthcare provider.

What has actually happened?

Three public incidents define the pattern.

December 2023. FDA and Novo Nordisk warned people not to use Ozempic 1 mg pens labeled with lot NAR0074 and serial number 430834149057 after counterfeits were found in the U.S. supply chain [1].

April 2025. Novo Nordisk notified FDA on April 3, 2025 that several hundred units of counterfeit Ozempic 1 mg carrying lot PAR0362 had been distributed outside its authorized supply chain and had reached the legitimate chain. FDA seized the identified product on April 9, 2025. FDA was aware of six adverse event reports associated with that lot number, though none appeared to be linked to the counterfeit product itself [2].

December 2025. FDA announced on December 5, 2025 that it had seized dozens of units of counterfeit Ozempic 1 mg labeled with lot number PAR1229. Novo Nordisk had notified the agency on November 18, 2025 [1][3].

In each case the counterfeiters copied a real lot number. That detail matters more than anything else in this article: matching a lot number against a legitimate one tells you nothing.

The single fastest check: where the EXP/LOT text sits

FDA and Novo Nordisk both point to the same tell on the pen label.

• Authentic Ozempic: the “EXP/LOT” text appears above the expiration date and lot number.
• Seized counterfeits: the “EXP/LOT” text appears to the left of the expiration date and lot number [1][3].

That is it. One glance at the pen label. If the text is on the left, do not use it and contact the pharmacy that dispensed it.

FDA added one clarification for the December 2025 incident: patients who received Ozempic 1 mg with lot number PAR1229 through the Novo Nordisk Patient Assistance Program may continue using it, because that product is authentic [1].

The needle check

Genuine Ozempic needles come sealed with a paper tab that is white on top and blue down the side, covering the needle. The blue portion is imprinted with the needle lot number and nothing else.

If the tab carries other text, or the seal looks wrong, treat it as suspect. FDA reported that the needles found with the seized counterfeits were themselves counterfeit, which means sterility cannot be confirmed and there is an added risk of infection on top of whatever is or is not in the cartridge [1].

The pen and packaging checks

Beyond the label and needle, several physical details have been reported in counterfeit samples and in consumer-safety guidance:

• A pen with a purple end cap rather than the expected color.
• A white dose dial that expands as you turn it, which an authentic pen does not do.
• Misspellings anywhere on the carton or label, including small ones in the fine print.
• Fonts that do not match across the carton, the label, and the pen body.
• Broken or resealed security seals on the carton.
• Text in the wrong language, or a carton that looks like it was printed for a different country’s market.

None of these is definitive on its own. Any one of them is a reason to stop and ask the pharmacy.

What FDA says is inside a counterfeit

The honest answer is that nobody knows. FDA has said it does not know the identity, quality, sterility, or safety of the seized products, and that testing was ongoing [1][3]. Novo Nordisk said visual examination of the seized product showed counterfeit features but that composition had not been conclusively determined [3].

Counterfeits found in other countries have contained insulin instead of semaglutide, which can cause dangerous low blood sugar. That is a reported pattern rather than a finding about these specific U.S. seizures, but it is why the advice is unambiguous: do not use a suspect pen to “see what happens.”

Where counterfeits come from, and how to stay out of their path

Counterfeit and unapproved semaglutide reaches U.S. patients through a few recognizable channels.

Outside the authorized distributor chain. The 2025 incidents involved product distributed outside Novo Nordisk’s authorized supply chain that then entered the legitimate one. FDA and Novo both advise pharmacies to buy authentic Ozempic and other semaglutide medicines only through authorized Novo Nordisk distributors [3].

Overseas online pharmacies. Sites that sell a prescription drug without a prescription, ship from another country, or take payment only by cryptocurrency or bank transfer are outside every safeguard the U.S. system has.

“Research use only” peptide vendors. These sell semaglutide powder with no prescription and no pharmacy involvement, labeled not for human consumption. FDA has issued warning letters treating those sellers as marketers of unapproved new drugs, and has warned that some products sold this way contain salt forms such as semaglutide sodium or semaglutide acetate, which the agency considers different active ingredients from the semaglutide in approved medicines [5][7].

Social media and secondhand resale. Buying anyone else’s leftover pens means buying an unknown storage history from an unknown source, even if the pen itself is genuine.

The practical rule: buy only from a licensed U.S. pharmacy, a manufacturer direct channel such as NovoCare Pharmacy or LillyDirect, or a telehealth service that fills your prescription through one of those [6].

A simple verification routine

Run this every time a new box arrives, not just once.

1. Check the EXP/LOT placement on the pen label. Above the date and lot number is expected; to the left is a red flag.
2. Check the needle tab. White on top, blue down the side, needle lot number only.
3. Read the carton closely. Spelling, fonts, seals, and country of labeling.
4. Check the dose dial. It should turn without the white dial expanding.
5. Compare against your last box if you have one. Differences in printing between refills are worth a phone call.
6. Ask the pharmacy where it sourced the product. A licensed pharmacy will be able to tell you whether it buys through an authorized distributor.
7. Keep the carton. If there is ever a question, the lot number and serial number are on it.

What to do if you think your pen is counterfeit

Stop using it. Do not inject another dose to test the theory.

Contact a healthcare provider, especially if you have had unusual symptoms. Signs of very low blood sugar — shakiness, sweating, confusion, rapid heartbeat — are a reason to seek care promptly, because counterfeits found elsewhere have contained insulin.

Call Poison Control at 1-800-222-1222 for guidance on a suspected exposure. It is free and available 24 hours a day.

Report it. File a report with FDA MedWatch and tell Novo Nordisk. Reporting is how the next seizure happens.

Tell the pharmacy that dispensed it and keep the packaging. Pharmacies are advised to review FDA’s published counterfeit photographs and to contact Novo Nordisk with questions [3].

Why this is getting harder, not easier

Two forces are pushing in opposite directions.

On one side, the supply chain has tightened. FDA established Import Alert 66-80 and a “green list” of GLP-1 active ingredient manufacturers in September 2025, so ingredient shipments from unvetted foreign facilities can be detained at the border without physical examination. Branded self-pay prices have also fallen sharply, which removes some of the desperation that drives people to gray channels.

On the other side, demand is enormous and global, and the shadow market has professionalized. Analysts describe a well-organized trade in unapproved semaglutide operating through research-peptide branding and overseas fulfillment [7]. Counterfeiters follow margin, and GLP-1s still carry a lot of it.

The defensive posture has not changed: buy inside the licensed chain, check the pen every time, and report anything that looks off.

Sources

1. FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain — FDA
2. FDA MedWatch: Counterfeit Ozempic in U.S. Drug Supply Chain (April 2025 seizure) — FDA
3. Novo Nordisk warns consumers about counterfeit Ozempic (semaglutide) injection 1 mg in the US — Novo Nordisk company statement, December 5, 2025
4. FDA Alert: More Counterfeit Ozempic found in U.S. Supply Chain — Partnership for Safe Medicines
5. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — FDA
6. Wegovy (semaglutide) Online Pharmacy — NovoCare Pharmacy
7. Explainer: The Thriving Shadow Market of GLP-1s for Weight Loss — BioSpace